Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. CDC confirms evidence of local monkeypox transmission

Published 06/23/2022, 05:33 PM
Updated 06/23/2022, 06:46 PM
© Reuters. FILE PHOTO: Test tubes labelled "Monkeypox virus positive" are seen in this illustration taken May 22, 2022. REUTERS/Dado Ruvic/Illustration/File Photo

(Reuters) -The U.S. Centers for Disease Control and Prevention (CDC) said there was evidence of local transmission of monkeypox, in addition to reports of cases where people had traveled abroad.

The cases are mainly occurring in men who have sex with men, but women are also getting infected, CDC staff member Dr. Agam Rao said at a panel meeting on Thursday.

Monkeypox, a viral infection that causes skin lesions, is endemic in certain parts of Africa. But the current outbreak has hit countries where the virus does not usually spread, sparking concern.

The CDC said had also been reports of transmission among family members and close contacts.

"We also heard worldwide about close contacts like close household members who through example shared bedding, towels, have acquired infection," Rao said. "So it is not just through close intimate contact that this is being spread."

The lesions associated with the present outbreak are also smaller than those typical of classic monkeypox, according to the public health agency.

The CDC last month published guidelines recommending the use of Bavarian Nordic's Jynneos vaccine for laboratory personnel and other at-risk people, making another vaccine available in addition to Emergent BioSolutions' ACAM2000.

Earlier on Thursday, New York City opened a temporary clinic to administer the two-dose Jynneos vaccine to eligible people who may have been exposed to monkeypox, including gay and bisexual men.

While there have been cases of heart inflammation called myocarditis associated with ACAM2000, no such cases have been reported yet after the use of Jynneos, the CDC said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

There is a limited supply of Jynneos and the agency is considering how to best use the supplies, it said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.